Digestive System Diseases Clinical Trials

7 recruiting

Digestive System Diseases Trials at a Glance

7 actively recruiting trials for digestive system diseases are listed on ClinicalTrialsFinder across 6 cities in 15 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Taipei, Houston, and Barcelona. Lead sponsors running digestive system diseases studies include Medtronic - MITG, Pfizer, and Jiangxi Provincial Cancer Hospital.

Browse digestive system diseases trials by phase

Treatments under study

About Digestive System Diseases Clinical Trials

Looking for clinical trials for Digestive System Diseases? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Digestive System Diseases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Digestive System Diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 3

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Colorectal NeoplasmsNeoplasms by SiteGastrointestinal Neoplasms+7 more
Pfizer800 enrolled156 locationsNCT07222800
Recruiting
Not Applicable

Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections

Postoperative ComplicationsAnastomotic LeaksAnastomotic Complication+8 more
Medtronic - MITG137 enrolled8 locationsNCT07351071
Recruiting
Not Applicable

Intestinal Organoids

Crohn DiseaseDigestive System DiseasesInflammatory Bowel Disease, Ulcerative Colitis Type
Rennes University Hospital90 enrolled1 locationNCT05294107
Recruiting
Not Applicable

Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer.

Head and Neck NeoplasmsEsophageal NeoplasmsNeoplasms+6 more
Taipei Veterans General Hospital, Taiwan20 enrolled1 locationNCT06365866
Recruiting
Phase 2

XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma

Gastric CancerGastroesophageal-junction CancerCarcinoma+4 more
The First Affiliated Hospital with Nanjing Medical University80 enrolled1 locationNCT05494060
Recruiting

Spanish Series of Patients Treated With the Radionuclide Lutetium177

Stomach NeoplasmsNeuroendocrine TumorsNeoplasms+15 more
Sociedad Española de Medicina Nuclear e Imagen Molecular5,000 enrolled20 locationsNCT04949282
Recruiting
Phase 2

Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients

Esophageal Squamous Cell CarcinomaEsophageal NeoplasmsNeoplasms by Site+8 more
Jiangxi Provincial Cancer Hospital30 enrolled1 locationNCT05252078